普萘洛尔治疗桥本病伴发甲状腺功能亢进的临床效果  

Clinical effects of propranolol in the treatment of Hashimoto disease con-comitant with hyperthyroidism

作　　者：朱红斌[1] 

机构地区：[1]江苏省东台市人民医院内分泌科,江苏东台224200

出　　处：《中国当代医药》2015年第21期70-72,共3页China Modern Medicine

摘　　要：目的分析普萘洛尔治疗桥本病伴发甲状腺功能亢进的临床结果。方法抽选2013年1月-2014年12月本院接收的桥本病伴发甲状腺功能亢进患者60例,按临床自愿接受治疗方法平均分成两组（医治组、对照组）,医治组患者给予普萘洛尔药物治疗,对照组患者给予临床常用抗甲状腺药物治疗,比较两组患者的临床治疗效果。结果医治组患者临床治疗好转率和对照组患者相比（93.3%vs 73.3%）,差异有统计学意义（P〈0.05）;医治组患者并发症发生率低于对照组（6.7%vs 26.7%）,差异有统计学意义（P〈0.05）。结论普萘洛尔治疗桥本病伴发甲状腺功能亢进安全、可靠,可改善其临床症状、减少并发症,意义重大,值得推广。Objective To analyze the clinical results of propranolol in the treatment of Hashimoto disease concomitant with hyperthyroidism. Methods 60 patients with Hashimoto disease concomitant with hyperthyroidism who were admit- ted to our hospital from January 2013 to December 2014 were selected.They were evenly assigned to two groups （treat- ment group and control group） according to their willingness of selecting clinical treatment.The treatment group was given medical treatment of propranolol,and the control group was given the treatment of clinically common anti-thyroid drugs.Clinical effects between two groups was compared respectively. Results Improvement rate of clinical treatment in treatment group was compared with that of control group （93.3% vs 73.3%）,with statistical difference（P〈0.05）;Total in- cidence of complications in treatment group was better than that in control group（6.7% vs 26.7%）,with statistical difference（P〈0.05）. Conclusion Propranolol applied in the treatment of Hashimoto disease concomitant with hyperthyroidism is safe and reliable,improves its clinical symptoms and reduces complications,which is of great significance and worthy of promotion.

关 键 词：普萘洛尔 桥本病 甲状腺功能亢进 临床疗效 

分 类 号：R977.14[医药卫生—药品]